RedHill Biopharma Ltd.
RDHL
$2.17
-$0.24-9.96%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/28/2025
-
GuruFocus
4/28/2025
-
GuruFocus
4/28/2025
-
GuruFocus
4/28/2025
-
The Fly
4/28/2025
-
PR Newswire
4/17/2025
-
GuruFocus
4/17/2025
-
GuruFocus
4/17/2025
-
GuruFocus
4/17/2025
-
TipRanks Financial Blog
4/17/2025
-
Seeking Alpha - Israel Stocks
4/17/2025
-
Seeking Alpha - Healthcare
4/17/2025
-
The Fly
4/17/2025
-
PR Newswire
4/16/2025
-
GuruFocus
4/16/2025
-
GuruFocus
4/16/2025
-
GuruFocus
4/16/2025
-
GuruFocus
4/16/2025
-
TipRanks Financial Blog
4/16/2025
-
The Fly
4/16/2025
-
PR Newswire
4/12/2025
-
Simply Wall St
4/10/2025
-
GuruFocus
4/10/2025
-
GuruFocus
4/10/2025
-
TipRanks Financial Blog
4/10/2025
-
PR Newswire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, April 10, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Aug 25 and 29 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 3 541 3131
Address
21 Ha’arba’a Street
Tel Aviv, 6473921
Tel Aviv, 6473921
Country
Year Founded
Business Description
Sector
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of...
more